메뉴 건너뛰기




Volumn 92, Issue 2, 2013, Pages 2163-2170

Conjugation of hyaluronan to proteins

Author keywords

Biodegradable polymers; Haylation; Hyaluronic acid; Protein delivery

Indexed keywords

BLOOD GLUCOSE LEVEL; CARBOXYLIC GROUP; DIRECT COUPLING; HAYLATION; HYALURONAN; IMMUNOGENICITY; N-TERMINALS; PEPTIDE LOADING; PROTEIN DELIVERY; RNASE A; SITE-SELECTIVE CONJUGATION; THERAPEUTIC PROTEIN;

EID: 84871542188     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2012.11.090     Document Type: Article
Times cited : (58)

References (35)
  • 3
    • 34250800861 scopus 로고    scopus 로고
    • Antibody against poly-(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients
    • J.K. Armstrong, G. Hempel, S. Koling, and L.S. Chan Antibody against poly-(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients Cancer 110 2007 103 111
    • (2007) Cancer , vol.110 , pp. 103-111
    • Armstrong, J.K.1    Hempel, G.2    Koling, S.3    Chan, L.S.4
  • 4
    • 84873744618 scopus 로고    scopus 로고
    • The chemistry, biology and medical applications of hyaluronan and its derivatives
    • T.C. Laurent, Portland Press London
    • E.A. Balazs, and T.C. Laurent The chemistry, biology and medical applications of hyaluronan and its derivatives T.C. Laurent, Round table discussion: New applications for hyaluronan 1998 Portland Press London 325 326
    • (1998) Round Table Discussion: New Applications for Hyaluronan , pp. 325-326
    • Balazs, E.A.1    Laurent, T.C.2
  • 5
    • 50349086791 scopus 로고    scopus 로고
    • A paclitaxel-hyaluronan bioconjugate targeting ovarian cancer affords a potent in vivo therapeutic activity
    • A. Banzato, S. Bobisse, M. Rondina, D. Renier, F. Bettella, and G. Esposito A paclitaxel-hyaluronan bioconjugate targeting ovarian cancer affords a potent in vivo therapeutic activity Clinical Cancer Research 14 2008 3598 3606
    • (2008) Clinical Cancer Research , vol.14 , pp. 3598-3606
    • Banzato, A.1    Bobisse, S.2    Rondina, M.3    Renier, D.4    Bettella, F.5    Esposito, G.6
  • 8
    • 43149109689 scopus 로고    scopus 로고
    • Polymer masked-unmasked protein therapy (PUMPT) 1. Bioresponsive dextrin-trypsin and -MSH conjugates designed for alpha-amylase activation
    • R. Duncan, H.R.P. Gilbert, R.J. Carbajo, and M.J. Vicent Polymer masked-unmasked protein therapy (PUMPT) 1. Bioresponsive dextrin-trypsin and -MSH conjugates designed for alpha-amylase activation Biomacromolecules 9 2008 1146 1154
    • (2008) Biomacromolecules , vol.9 , pp. 1146-1154
    • Duncan, R.1    Gilbert, H.R.P.2    Carbajo, R.J.3    Vicent, M.J.4
  • 9
    • 67049117930 scopus 로고    scopus 로고
    • Dextrin-phospholipase A2: Synthesis and evaluation as a novel bioresponsive anticancer conjugate
    • E.L. Ferguson, and R. Duncan Dextrin-phospholipase A2: synthesis and evaluation as a novel bioresponsive anticancer conjugate Biomacromolecules 10 2009 1358 1364
    • (2009) Biomacromolecules , vol.10 , pp. 1358-1364
    • Ferguson, E.L.1    Duncan, R.2
  • 10
    • 0026816560 scopus 로고
    • Increased activity and stability of poly(ethylene glycol)-modified trypsin
    • H.F. Gaertner, and A.J. Puigserver Increased activity and stability of poly(ethylene glycol)-modified trypsin Enzyme and Microbial Technology 14 1992 150 155
    • (1992) Enzyme and Microbial Technology , vol.14 , pp. 150-155
    • Gaertner, H.F.1    Puigserver, A.J.2
  • 15
    • 79957988813 scopus 로고    scopus 로고
    • N-terminal specificity of PEGylation of human bone morphogenetic protein-2 at acidic pH
    • J. Hu, and W. Sebald N-terminal specificity of PEGylation of human bone morphogenetic protein-2 at acidic pH International Journal of Pharmaceutics 413 2011 140 146
    • (2011) International Journal of Pharmaceutics , vol.413 , pp. 140-146
    • Hu, J.1    Sebald, W.2
  • 16
    • 0001243390 scopus 로고
    • A modified spectrophotometric determination of chymotrypsin, trypsin, and thrombin
    • B.C. Hummel A modified spectrophotometric determination of chymotrypsin, trypsin, and thrombin Canadian Journal of Biochemistry and Physiology 37 1959 1393 1399
    • (1959) Canadian Journal of Biochemistry and Physiology , vol.37 , pp. 1393-1399
    • Hummel, B.C.1
  • 19
    • 84860667754 scopus 로고    scopus 로고
    • Selective conjugation of poly(2-ethyl 2-oxazoline) to granulocyte colony stimulating factor
    • A. Mero, Z. Fang, G. Pasut, F.M. Veronese, and T.X. Viegas Selective conjugation of poly(2-ethyl 2-oxazoline) to granulocyte colony stimulating factor Journal of Controlled Release 159 2012 353 361
    • (2012) Journal of Controlled Release , vol.159 , pp. 353-361
    • Mero, A.1    Fang, Z.2    Pasut, G.3    Veronese, F.M.4    Viegas, T.X.5
  • 20
    • 37449007276 scopus 로고    scopus 로고
    • Synthesis and characterization of poly(2-ethyl 2-oxazoline)-conjugates with proteins and drugs: Suitable alternatives to PEG-conjugates?
    • A. Mero, G. Pasut, L. Dalla Via, M.W. Fijten, U.S. Schubert, and R. Hoogenboom Synthesis and characterization of poly(2-ethyl 2-oxazoline)- conjugates with proteins and drugs: Suitable alternatives to PEG-conjugates? Journal of Controlled Release 125 2008 87 95
    • (2008) Journal of Controlled Release , vol.125 , pp. 87-95
    • Mero, A.1    Pasut, G.2    Dalla Via, L.3    Fijten, M.W.4    Schubert, U.S.5    Hoogenboom, R.6
  • 21
    • 51549092094 scopus 로고    scopus 로고
    • The impact of PEGylation on biological therapies
    • A. Mero, and F.M. Veronese The impact of PEGylation on biological therapies BioDrugs 22 2008 315 329
    • (2008) BioDrugs , vol.22 , pp. 315-329
    • Mero, A.1    Veronese, F.M.2
  • 22
    • 84861600904 scopus 로고    scopus 로고
    • Chitosan, hyaluronan and chondroitin sulfate in tissue engineering for cartilage regeneration: A review
    • R.A.A. Muzzarelli, F. Greco, A. Busilacchi, V. Sollazzo, and A. Gigante Chitosan, hyaluronan and chondroitin sulfate in tissue engineering for cartilage regeneration: A review Carbohydrate Polymers 89 2012 723 739
    • (2012) Carbohydrate Polymers , vol.89 , pp. 723-739
    • Muzzarelli, R.A.A.1    Greco, F.2    Busilacchi, A.3    Sollazzo, V.4    Gigante, A.5
  • 23
    • 84859808294 scopus 로고    scopus 로고
    • In situ forming hydrogels of new amino hyaluronic acid/benzoyl-cysteine derivatives as potential scaffolds for cartilage regeneration
    • F.S. Palumbo, G. Pitarresi, C. Fiorica, P. Matricardi, G. Albanese, and G. Giammona In situ forming hydrogels of new amino hyaluronic acid/benzoyl-cysteine derivatives as potential scaffolds for cartilage regeneration Soft Matter 8 2012 4918 4924
    • (2012) Soft Matter , vol.8 , pp. 4918-4924
    • Palumbo, F.S.1    Pitarresi, G.2    Fiorica, C.3    Matricardi, P.4    Albanese, G.5    Giammona, G.6
  • 25
    • 34547607522 scopus 로고    scopus 로고
    • Polymer-drug conjugation, recent achievements and general strategies
    • G. Pasut, and F.M. Veronese Polymer-drug conjugation, recent achievements and general strategies Progress in Polymer Science 32 2007 933 961
    • (2007) Progress in Polymer Science , vol.32 , pp. 933-961
    • Pasut, G.1    Veronese, F.M.2
  • 26
    • 84861749627 scopus 로고    scopus 로고
    • State of the art in PEGylation: The great versatility achieved after forty years of research
    • G. Pasut, and F.M. Veronese State of the art in PEGylation: The great versatility achieved after forty years of research Journal of Controlled Release 161 2012 461 472
    • (2012) Journal of Controlled Release , vol.161 , pp. 461-472
    • Pasut, G.1    Veronese, F.M.2
  • 29
    • 36549089052 scopus 로고    scopus 로고
    • PEGuricase in the management of treatment-resistant gout and hyperuricemia
    • M.R. Sherman, M.G. Saifer, and F. Perez-Ruiz PEGuricase in the management of treatment-resistant gout and hyperuricemia Advanced Drug Delivery Reviews 6 2008 59 68
    • (2008) Advanced Drug Delivery Reviews , vol.6 , pp. 59-68
    • Sherman, M.R.1    Saifer, M.G.2    Perez-Ruiz, F.3
  • 34
    • 80052963561 scopus 로고    scopus 로고
    • Target specific hyaluronic acid-interferon alpha conjugate for the treatment of hepatitis C virus infection
    • J.A. Yang, K. Park, H. Jung, H. Kim, S.W. Hong, and S.K. Yoon Target specific hyaluronic acid-interferon alpha conjugate for the treatment of hepatitis C virus infection Biomaterials 32 2011 8722 8729
    • (2011) Biomaterials , vol.32 , pp. 8722-8729
    • Yang, J.A.1    Park, K.2    Jung, H.3    Kim, H.4    Hong, S.W.5    Yoon, S.K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.